COVID-19 Governance Pharmaceutical Industry 
Bill of Health
OCTOBER 26, 2023
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. This pattern has had lethal consequences during the COVID-19 pandemic, harming efforts to advance global solidarity.
Bill of Health
AUGUST 29, 2022
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” Pandemic Pledges. Moderna’s Pledge.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
MAY 5, 2023
The COVID-19 crisis demonstrated how the need for protecting and incentivizing innovation clashed with the need to make products widely available. To solve this tension, the Commission recognizes that patent law already offers a solution: compulsory licensing.
Bill of Health
DECEMBER 12, 2023
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. Impact of the judgment: what have records disclosed shown?
HIT Consultant
OCTOBER 25, 2022
– Samsung reduces the time required to label lung X-Rays used to diagnose COVID-19 by 84% by using AI to identify and then label the most informative images first. In addition to these challenges specific to their industry, pharma companies are all also presented with classic barriers to implementation.
Health Populi
JULY 1, 2020
health systems are projected to lose $323 billion in 2020 due to declining inpatient and outpatient volumes caused by the COVID-19 pandemic’s impact on the “normal” hospital business. Some hospitals in regions of these states are approaching full capacity in ICUs and COVID units. fall in outpatient volume.
Bill of Health
JULY 11, 2024
The experience of COVID-19 is estimated to have led to a 27.6% Between 2017 and 2021, the Peruvian, Chilean, Guatemalan, Uruguayan, Mexican, and Argentinian governments awarded the purchase of such medicines to single suppliers without a public tender or in favor of companies with bad corporate practices.
Expert insights. Personalized for you.
303 
Let's personalize your content